VAXIPAK

AN INNOVATIVE DELIVERY DEVICE TO RECONSTITUTE SOLIDS AND LIQUIDS IN A SINGLE CONTAINER CLOSURE SYSTEM

Advantages
  • Single unit delivery device – Integrated reconstitution and administration.
  • Easy to transport.
  • Robust and sturdy device with optimal size.
  • Appropriate as an oral vaccine delivery device for paediatric use.
  • No choking hazard (spout cap).
  • Successful administration of complete dose.
  • Reduced wastage.
  • Easy to administer for geriatrics / adults.
  • Useful for the areas with low accessibility of drugs.
Critical Quality Attributes evaluated
  • Container-closure integrity testing.
  • Water vapour transmission rate (WVTR).
  • Temperature inside the chamber at the time of sealing.
Current Status
  • Availability of pilot scale equipment from a Swiss manufacturer.
  • Trained personnel to operate equipment.
  • Design patent filed.
Application
  • Solid (powder, microbeads, granules etc.) and Liquid dose administration.

Future applications of VAXIPAK for pharma domain

Output: up to 1000 pouches / shift of 8 hours